Skip to main content
. Author manuscript; available in PMC: 2016 Mar 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2014 Aug 19;13(3):594–601.e1. doi: 10.1016/j.cgh.2014.08.013

Table 3.

Results from a multivariable Cox proportional hazards model examining risk of mortality among HCC patients with underlying NAFLD, alcohol abuse or HCV

Adjusted Hazard Ratio (95% CI)
Risk factor
  NAFLD 0.8 (0.6–1.0)
  Alcohol abuse 0.9 (0.8–1.2)
  HCV 1.0 (Reference)
Age 1.0 (0.9–1.0)
Race
  White 1.0 (Reference)
  Black 1.1 (0.9–1.3)
  Hispanic 1.0 (0.8–1.2)
  Others 1.0 (0.6–1.5)
MELD score
  <10 1.0 (Reference)
  10–19.9 1.4 (1.3–1.7)
  20+ 1.4 (1.1–1.9)
Deyo index
  0 1.0 (Reference)
  1 1.0 (0.8–1.2)
  2+ 1.0 (0.8–1.1)
BCLC stage
  A 1.0 (Reference)
  B 1.7 (1.4–2.2)
  C 2.7 (2.2–3.3)
  D 4.2 (3.4–5.5)
Any HCC Surveillance
  Yes 0.8 (0.7–0.9)
  No 1.0 (Reference)
HCC Treatment
  Curative (resection, transplantation, ablation) 0.3 (0.2–0.3)
  Palliative (TACE, chemotherapy) 0.5 (0.5–0.6)
  No treatment 1.00 (Reference)